Vohra Wound Physicians Responds to Department of Justice Lawsuit
Vohra has been actively engaged in discussions with the Government regarding this matter since first receiving a subpoena in
Contrary to the DOJ's allegations, Vohra physicians exercised their independent clinical judgment in making treatment decisions, and Vohra proudly stands by our doctors and the care they provided. The complaint initiating the lawsuit includes several factual errors about Vohra's electronic medical records ("EMR") system. Our patients and positive clinical outcomes always come first.
The case largely comes down to varying interpretations of ambiguous Medicare billing codes that do not clearly distinguish between selective and surgical debridements, as well as differing treatment philosophies. The choice between selective and surgical debridements often comes down to merely managing a wound versus actively healing a wound. Objective clinical data and studies show that Vohra's treatment approach succeeds in healing wounds.
Vohra acted lawfully and responsibly, but is open to an amicable resolution with the DOJ to avoid the delay, uncertainty, and expense of protracted litigation. If a reasonable resolution is not possible, the company will vigorously defend itself in court.
View original content to download multimedia:https://www.prnewswire.com/news-releases/vohra-wound-physicians-responds-to-department-of-justice-lawsuit-302422584.html
SOURCE Vohra Wound Physicians Management, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UN Global Compact Leaders Summit calls on business leaders to turn sustainability ambition into action at scale
- Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
- CHIME Announces New Board Members and Officers, Strengthening Leadership Through 2029
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share